F007 Hair Loss in Women
DESCRIPTION
This session will review the diagnosis and treatment of hair loss in women including female pattern hair loss, frontal fibrosing alopecia, and central centrifugal cicatricial alopecia. Potential genetic and/or environmental etiologic factors for each will be discussed. Safety and efficacy of both topical and oral medications and procedural treatments such as PRP and hair transplants will be presented. The speakers will share pearls from their respective hair disorder practices as well.
LEARNING OBJECTIVES
Determine how and when to safely and effectively prescribe oral minoxidil, 5 alfa reductase inhibitors, anti androgens, PRP and hair transplants in both nonscarring and scarring alopecias.
Recognize the common and unique genetic and environmental factors that may cause the different subtypes of cicatricial alopecia.
Effectively manage FPHL, FFA and CCCA in your clinic.
SCHEDULE
9:00 AM
Medical treatment of female pattern hair loss
Elise A. Olsen, MD, FAAD
9:22 AM
Etiology of cicatricial alopecia—genetics vs environment
Amy J McMichael, MD, FAAD
9:44 AM
Medical treatment of frontal fibrosing alopecia
Jerry Shapiro, MD, FAAD
10:06 AM
Medical treatment of central centrifugal cicatricial alopecia
Crystal Aguh, MD, FAAD
10:28 AM
Procedural treatments for hair loss: Mesotherapy with antiandrogens, injected triamcinolone, PRP, botulinum toxin, microneedling and hair transplantation
Sergio Vano-Galvan, MD, PhD, IFAAD
10:50 AM
Panel discussion
DIRECTOR
Elise A. Olsen, MD, FAAD
SPEAKERS
Crystal Aguh, MD, FAAD
Amy J McMichael, MD, FAAD
Jerry Shapiro, MD, FAAD
Sergio Vano-Galvan, MD, PhD, IFAAD
HANDOUTS
DISCLOSURES
Crystal Aguh, MD, FAAD
CP Skin Health – Advisory Board(Honoraria); Eli Lilly and Company – Consultant(Fees); Johnson & Johnson – Other(Residency/Fellowship Program Funding); Pfizer Inc. – Consultant(Fees); Procter & Gamble Company – Consultant (1099 relationship)(Fees); UpToDate, Inc – Other(Fees); Veradermics – Advisory Board(Fees);
Amy J McMichael, MD, FAAD
Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Apogee BioPharm – Advisory Board(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Nutrafol – Advisory Board(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Elise A. Olsen, MD, FAAD
Absci – Advisory Board(Honoraria); Aranda Pharm Ltd – Consultant (1099 relationship)(Honoraria); Canfield Scientific, Inc. – Consultant(Honoraria); Cosmos – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Taisho Pharmaceuticals Co., Ltd. – Consultant (1099 relationship)(Honoraria); United States Cutaneous Lymphoma Consortium – Other(Grants/Research Funding); UpToDate, Inc – Other(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Jerry Shapiro, MD, FAAD
30 Madison – Consultant (1099 relationship)(Stock Options); AbbVie – Consultant (1099 relationship)(Honoraria); Almirall – Consultant (1099 relationship)(Honoraria); DS Laboratories – Consultant (1099 relationship)(Honoraria); Eirion Therapeutics – Consultant (1099 relationship)(Stock Options); Eli Lilly – Advisory Board(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Veradermics – Consultant (1099 relationship)(Fees), Stockholder Public Company(No Compensation Received);
Sergio Vano-Galvan, MD, PhD, IFAAD
AbbVie – Speaker(Fees); Cantabria Labs – Advisory Board(Fees); Fotofinder – Speaker(Fees); L'Oréal France – Advisory Board(Fees); Lilly ICOS LLC – Advisory Board(Fees); Pfizer Inc. – Advisory Board(Fees); Pierre Fabre Dermatologie – Speaker(Fees);